TM patients (mean ± SD) [95% CI] |
Controls (mean ± SD) [95% CI] | P value | |
---|---|---|---|
Males | |||
RVEDVI (mL/m2) |
98.1 ± 17.3 [64.2 -- 132.0] |
88.4 ± 11.2 [66.5 -- 110.4] | 0.027 |
RVESVI (mL/m2) |
33.2 ± 8.0 [17.5 -- 48.8] |
33.8 ± 5.0 [24.0 -- 43.7] | 0.77 |
RVSVI (mL/m2) |
64.7 ± 11.2 [42.7 -- 86.6] |
54.7 ± 10.3 [34.6 -- 74.8] | 0.0015 |
RVEF (%) |
66.2 ± 4.1 [58.0 -- 74.3] |
61.6 ± 6.0 [50.0 -- 73.3] | 0.0009 |
RVMI (g/m2) |
38.8 ± 7.9 [23.3 -- 54.4] |
36.4 ± 7.8 [21.1 -- 51.7] | 0.27 |
CO (L/min) |
7.9 ± 1.9 [4.16 -- 11.5] |
6.6 ± 1.6 [3.4 -- 9.8] | 0.014 |
CI (L/min/m2) |
4.8 ± 1.0 [2.9 -- 6.7] |
3.4 ± 0.7 [2.0 -- 4.8] | <0.0001 |
Females | |||
RVEDVI (mL/m2) |
86.5 ± 13.6 [59.8 -- 113.2] |
80.3 ± 12.8 [55.3 -- 105.3] | 0.093 |
RVESVI (mL/m2) |
29.2 ± 7.2 [15.1 -- 43.2] |
30.3 ± 8.6 [13.5 -- 47.1] | 0.58 |
RVSVI (mL/m2) |
57.4 ± 9.2 [39.4 -- 75.5] |
50.0 ± 7.8 [34.7 -- 65.2] | 0.0030 |
RVEF (%) |
66.3 ± 5.1 [56.4 -- 76.2] |
62.6 ± 6.4 [50.1 -- 75.0] | 0.017 |
RVMI (g/m2) |
34.0 ± 7.7 [18.8 -- 49.1] |
30.8 ± 5.3 [20.5 -- 41.1] | 0.11 |
CO (L/min) |
6.8 ± 1.7 [3.5 -- 10.1] |
5.5 ± 1.5 [2.5 -- 8.4] | 0.0033 |
CI (L/min/m2) |
4.5 ± 0.8 [2.9 -- 6.2] |
3.2 ± 0.8 [1.7 -- 4.8] | <0.0001 |